User:Mr. Ibrahem/Vosoritide

Vosoritide, sold under the brand name Voxzogo, is a medication used to treat achondroplasia (dwarfism). Specifically it is used in those who are at least two to five years old and still growing. It is given by injection under the skin.

Common side effects include injection site swelling, redness, itching, or pain; vomiting; and low blood pressure. Safety in pregnancy is unclear. It works by binding to a specific receptor called natriuretic peptide receptor-B, which reduces FGFR3, and therefore increases bone growth.

Vosoritide was approved for medical use in Europe and the United States in 2021. In France it costs about 260,000€ per year as of 2022. This amount in the United States costs about 330,000 USD.